Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2400707 | 1.00 | TSHR (0.41) | TSHRCYP3A4MEN1ALOX15KMT2A | |
| SCHEMBL19812427 | 0.83 | ALDH1A1 (0.43) | TSHRCYP3A4MEN1ALOX15KMT2A | |
| SCHEMBL8909426 | 0.81 | LMNA (0.52) | CYP3A4MEN1ALOX15KMT2AALDH1A1 | |
| SCHEMBL17885433 | 0.81 | LMNA (0.52) | CYP3A4MEN1ALOX15KMT2AALDH1A1 | |
| SCHEMBL15822080 | 0.81 | LMNA (0.52) | CYP3A4MEN1ALOX15KMT2AALDH1A1 | |
| SCHEMBL15825970 | 0.81 | LMNA (0.52) | CYP3A4MEN1ALOX15KMT2AALDH1A1 | |
| SCHEMBL17268254 | 0.81 | LMNA (0.52) | CYP3A4MEN1ALOX15KMT2AALDH1A1 | |
| SCHEMBL8909436 | 0.81 | LMNA (0.52) | CYP3A4MEN1ALOX15KMT2AALDH1A1 | |
| SCHEMBL13839555 | 0.75 | TSHR (0.46) | TSHRCYP3A4MEN1ALOX15KMT2A | |
| SCHEMBL3897447 | 0.75 | TSHR (0.46) | TSHRCYP3A4MEN1ALOX15KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8026081-B2 | Method of producing optically active (S)-7-hydroxy-6-methylheptan-2-one and precursor thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-09-27 | — | — | US | disclosed |
| US-20090118534-A1 | METHOD OF PRODUCING OPTICALLY ACTIVE (S)-7-HYDROXY-6-METHYLHEPTAN-2-ONE AND PRECURSOR THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-05-07 | — | — | US | disclosed |
| EP-2003211-A9 | PROCESS FOR PRODUCING OPTICALLY ACTIVE (S)-7-HYDROXY-6-METHYLHEPTANE-2-ONE AND PRECURSOR THEREOF | Sumitomo Chemical Company, Limited (JP) | 2009-05-06 | — | — | EP | disclosed |
| EP-2003211-A2 | PROCESS FOR PRODUCING OPTICALLY ACTIVE (S)-7-HYDROXY-6-METHYLHEPTANE-2-ONE AND PRECURSOR THEREOF | Sumitomo Chemical Company, Limited (JP) | 2008-12-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090118534-A1 | METHOD OF PRODUCING OPTICALLY ACTIVE (S)-7-HYDROXY-6-METHYLHEPTAN-2-ONE AND PRECURSOR THEREOF | APEH, BCHE, CYP51A1 | TSHR 2079/4885CYP3A4 174/4885MEN1 1024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.